Multidrug-Resistant Salmonella enterica Serovar Typhi Isolates with High-Level Resistance to Ciprofloxacin in Dhaka, Bangladesh
Open Access
- 1 October 2006
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 50 (10) , 3516-3517
- https://doi.org/10.1128/aac.00667-06
Abstract
Typhoid fever due to multidrug-resistant Salmonella enterica serovar Typhi is a global public health problem, with an estimated 30 million cases and 600,000 deaths annually ([7][1]). Since the beginning of the 1990s, there has been an increasing prevalence of multidrug resistance to the first-lineThis publication has 6 references indexed in Scilit:
- High-level ciprofloxacin resistance in Salmonella enterica serotype Typhi in IndiaJournal of Medical Microbiology, 2005
- Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin—an emerging problem in BangladeshInternational Journal of Antimicrobial Agents, 2005
- Emergence of Multidrug-Resistant Salmonella enterica Serovar Typhi in KoreaAntimicrobial Agents and Chemotherapy, 2004
- DNA Sequence Analysis of DNA Gyrase and DNA Topoisomerase IV Quinolone Resistance-Determining Regions of Salmonella enterica Serovar Typhi and Serovar Paratyphi AAntimicrobial Agents and Chemotherapy, 2002
- A HIGHLY CEFTRIAXONE-RESISTANT SALMONELLA TYPHI IN BANGLADESHThe Pediatric Infectious Disease Journal, 1999
- Epidemic ciprofloxacin-resistant Salmonella typhi in TajikistanThe Lancet, 1998